Conoscere EBM
- Definizione
- Acronimi
- Cronologia
- Ambiti
- Know-how e strumenti
- EBM in 4 step
- Limiti e ostacoli

EB Practice
- Formulazione quesito
- Ricerca evidenze
- Valutazione evidenze
- Applicazione evidenze

EBHC Library
- Risorse in italiano

SSN Hot Topics
- Appropriatezza
- Conflitti di interesse
- ECM
- Farmaci
- Governo Clinico
- LEA

InfoSanità

Archivio > News 2002

Page last update: 08/01/2008

• Sito GIMBE^â

  • Interamente aggiornate le pagine sulle linee guida

    • Linee guida (searching)

    • Linee guida (electronic-library)

• JAMA, 1 gennaio

  • The Rational of Clinical Examination. Does This Patient Have Acute Cholecystitis?

  • Improving Reports of Studies of Diagnostic Tests The STARD Initiative

  

• BMJ, 21 dicembre. Christmas issue

  • Four futures for scientific and medical publishing

  • Is that it? How online articles have changed over the past five years

  • EBM: unmasking the ugly truth

• BMJ, 14 dicembre

  • Evaluating treatment effects reliably

  • Making progress with competing interests

  • Does declaration of competing interests affect readers' perceptions? A randomised trial

  • Managing acute renal colic across the primary-secondary care interface: a pathway of care based on evidence and consensus

• N Engl J Med, 12 dicembre

  • Patient Safety: Views of Practicing Physicians and the Public on Medical Errors

  • A Broader Concept of Medical Errors

• JAMA, 11 dicembre

  • Interventions to Enhance Patient Adherence to Medication Prescriptions Scientific Review

  • Helping Patients Follow Prescribed Treatment Clinical Applications

  

• BMJ, 7 dicembre

  • A clinical trials register for Europe

  • Do short courses in evidence based medicine improve knowledge and skills? Validation of Berlin questionnaire and before and after study of courses in evidence based medicine

  • Values and leadership

• Lancet, 7 dicembre

  • The second greatest benefit to mankind?

  • The need for resources for clinical research: the European Society of Cardiology calls for European, international collaboration

  

• Consorzio Mario Negri Sud

  • Progetto Etica e Sperimentazione Clinica (Research Group on Rights and Ethics in Medicine/Human Experimentation)

• Occhio Clinico, novembre 2002

  • Inutile (se non fuorviante) l’efficacia solo sulla carta

  • Tra il dire e il fare niente traghetti

• BMJ, 30 novembre

  • Systematic review of involving patients in the planning and development of health care

  • Involving users in the delivery and evaluation of mental health services: systematic review

  • Reconfiguring health systems

• Bandolier, novembre 2003

• CMAJ, 26 novembre

  • The controlling interests of research

  • Comparative trial of a short workshop designed to enhance appropriate use of screening tests by family physicians

  • Pharmaceutical cost containment with reference-based pricing: time for refinements

• Arch Intern Med, 25 novembre

  • Analysis of Medication-Related Malpractice Claims Causes, Preventability, and Costs

  

• Lancet, 23 novembre

  • The power of the protocol

  • Acronymic trials: the good, the bad, and the coercive

  • Accountability of the pharmaceutical industry

  • Working towards ethical management of genetic testing

• BMJ, 23 novembre

  • Postal survey of approaches to learning among Ontario physicians: implications for continuing medical education

  • Institutional corruption in medicine

• MJA, 18 novembre

  • The Cochrane Library: access for all Australians

  • Randomisation in clinical trials

  

• Lancet, 16 novembre

  • The pharmaceutical industry as a medicines provider

• BMJ, 16 novembre

  • New BMJ policy on economic evaluations

  • Making regulation responsive to commercial interests: streamlining drug industry watchdogs

• N Engl J Med, 14 novembre

  • Patient Safety: Reporting of Adverse Events

• Lancet, 9 novembre

  • Improving ADR reporting

  • The pharmaceutical industry as a political player

  • Antiretroviral treatment in resource-poor settings: clinical research priorities

• BMJ, 9 novembre

  • Why general practitioners use computers and hospital doctors do not. Part 1: incentives

  • Why general practitioners use computers and hospital doctors do not. Part 2:scalability

• 9  novembre

  • Joint Meeting Associazione Medici Endocrinologi (AME)- American Association of Clinical Endocrinologists (AACE)

    • Clinical symposia

• MJA,  4 novembre

  • The ethics of participating in research

  • Clinicians' attitudes to clinical practice guidelines: a systematic review

  

• Bandolier, ottobre 2002

• Lancet, 2 novembre

  • An innovative challenge to the pharmaceutical industry

  • Clinical trial protocols: agreements between the FDA and industrial sponsors

  • Medicines, society, and industry

  • The pharmaceutical industry as an informant

• BMJ, 2 novembre

  • A POEM a week for the BMJ

  • Integrated narrative and evidence based case report: Case report of paroxysmal atrial fibrillation and anticoagulation

  • A strategy for tackling health inequalities in the Netherlands

  

• Lancet, 26 ottobre

  • Can transnational research be ethical in the developing world?

  • Comprehension during informed consent in a less-developed country

  • Reporting of ethical issues in publications of medical research

• BMJ, 26 ottobre

  • Interventions used in disease management programmes for patients with chronic illnesswhich ones work? Meta-analysis of published reports

  • Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomised controlled trial

  • Quality improvement report: Effect of a multifaceted approach to detecting and managing depression in primary care

  • Unwarranted variations in healthcare delivery: implications for academic medical centres

  • As good as it gets? Chronic care management in nine leading US physician organisations

• N Engl J Med, 24 ottobre

  • A National Survey of Provisions in Clinical-Trial Agreements between Medical Schools and Industry Sponsors

  • Institutions, Contracts, and Academic Freedom

  • Academic Freedom in Clinical Research

  • Collaborating with Industry — Choices for the Academic Medical Center

• MJA, 21 ottobre

  • Clinical trials and "real-world" medicine

  • Managing the resource demands of a large sample size in clinical trials: can you succeed with fewer subjects?

  

• BMJ, 19 ottobre

  • Learning in practice. Efficacy of case method learning in general practice for secondary prevention in patients with coronary artery disease: randomised controlled study

  • Cost effectiveness analysis in health care: contraindications

• Lancet, 19 ottobre

  • Visibility of research: FUTON bias

• N Engl J Med, 17 ottobre

  • A Series on Patient Safety

  • Patient Safety: Fatigue among Clinicians and the Safety of Patients

• Ann Intern Med, 15 ottobre

  • Rare Outcomes, Common Treatments: Analytic Strategies Using Propensity Scores

  

• BMJ, 12 ottobre

  • Volume of procedures and outcome of treatment

  • Learning in practice. Developing the role of patients as teachers: literature review

  • Evaluating complementary medicine: methodological challenges of randomised controlled trials

• MJA, 7 ottobre

  • Exceptional economic returns on investments in medical research

• BMJ, 5 ottobre

  • Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study

• Ann Intern Med, 1ottobre

  • Spectrum Bias or Spectrum Effect? Subgroup Variation in Diagnostic Test Evaluation

  

• Bandolier, settembre 2002

• BMJ, 28 settembre

  • Theme issue: What is a good doctor and how do you make one

• Ann Intern Med, 17 settembre

  • Is Volume Related to Outcome in Health Care? A Systematic Review and Methodologic Critique of the Literature

• MJA, 16 settembre

  • Pharmaceutical advertisement claims in Australian medical publications

  • Drug advertising: truths, half-truths and few statistics

• BMJ, 21 settembre

  • Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis

  

• BMJ, 14 settembre

  • Interpreting the evidence

  • Alosetron: a case study in regulatory capture, or a victory for patients' rights?

  

• BMJ, 7 settembre

  • Survey of public information about ongoing clinical trials funded by industry: evaluation of completeness and accessibility

• N Engl J Med, 5 settembre

  • Nonfinancial Conflicts of Interest in Research

• JAMA, 4 settembre

  • Evaluating the Teaching of Evidence-Based Medicine

  • Continuing Medical Education and the Physician as a Learner Guide to the Evidence

• MJA, 3 settembre

  • Potential pitfalls of healthcare performance indicators

  • Determining the sample size in a clinical trial

• Ann Intern Med, 3 settembre

  • Are Bad Outcomes from Questionable Clinical Decisions Preventable Medical Errors? A Case of Cascade Iatrogenesis

  • The Mammography Dilemma: A Crisis for Evidence-Based Medicine?

• Lancet, 30 agosto

  • A rational framework for decision making by the National Institute For Clinical Excellence (NICE)

  

• N Engl J Med, 5 settembre

  • Nonfinancial Conflicts of Interest in Research

• JAMA, 4 settembre

  • Evaluating the Teaching of Evidence-Based Medicine

  • Continuing Medical Education and the Physician as a Learner Guide to the Evidence

• MJA, 3 settembre

  • Potential pitfalls of healthcare performance indicators

  • Determining the sample size in a clinical trial

• Ann Intern Med, 3 settembre

  • Are Bad Outcomes from Questionable Clinical Decisions Preventable Medical Errors? A Case of Cascade Iatrogenesis

  • The Mammography Dilemma: A Crisis for Evidence-Based Medicine?

• Lancet, 30 agosto

  • A rational framework for decision making by the National Institute For Clinical Excellence (NICE)

  

• Lancet, 24 agosto

  • Systematic reviews of animal experiments

• BMJ, 24 agosto

  • Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial

  • "Food deserts"- evidence and assumption in health policy making

  • Working with the private sector: the need for institutional guidelines

• JAMA 21 agosto

  • Interpreting the Number Needed to Treat

• Lancet, 17 agosto

  • The next step: ensuring integrity of scientific research  

  • Addressing health inequalities

• BMJ, 17 agosto

  • Systematic reviews and lifelong diseases

• JAMA, 14 agosto

  • Financial Ties and Conflicts of Interest Between Pharmaceutical and Tobacco Companies

  • The Importance of the Journal Embargo

• Arch Intern Med, 12-26 agosto

  • Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials

  • Unnecessary Use of Placebo Controls. The Case of Asthma Clinical Trials

• Bandolier, agosto 2002

 

29 luglio - 4 agosto

• Bandolier, luglio 2002

• BMJ, 3 agosto

  • Counting the cost of medical negligence

  • Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ

  • Efficacy, safety, and cost of new anticancer drugs

  • Quality improvement report. Learning from adverse incidents involving medical devices

• Lancet, 3 agosto

  • Researchers' links with industry threaten basic research in Denmark

  • Research ethics committees and public dissemination of clinical trial results

  

• BMJ, 27 luglio

  • The world's most neglected diseases

  • Learning in practice. Valuing learners' experience and supporting further growth: educational models to help experienced adult learners in medicine

  • Quality improvement report: The "jaundice hotline" for the rapid assessment of patients with jaundice

• Lancet, 27 luglio

  • What kind of evidence do we need to justify humanitarian medical aid?

• JAMA, 24-31 luglio

  • What Practices Will Most Improve Safety? Evidence-Based Medicine Meets Patient Safety

  • Safe but Sound. Patient Safety Meets Evidence-Based Medicine

  

• JAMA, 17 luglio

  • The Continuing Unethical Conduct of Underpowered Clinical Trials

  • Informing Clinical Trial Participants About Study Results

• BMJ, 13 luglio

  • What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers

  • Economics Notes: Economic modelling before clinical trials

• Lancet, 13 luglio

  • Seminal pharmaceutical trials: maintaining masking in analysis

  • Rapid reviews in The Lancet--and beyond

  • Communication of risk: choice, consent, and trust

• CMAJ, 9 luglio

  • The invisible hand of the marketing department

• Arch Intern Med, 8 luglio

  • Lack of Evidence-Based Research for Idiopathic Low Back Pain The Importance of a Specific Diagnosis

  

• BMJ, 6 luglio

  • Ethics of undisclosed payments to doctors recruiting patients in clinical trials

• BMJ, 29 giugno

  • An observational study comparing quality of care in walk-in centres with general practice and NHS Direct using standardised patients

  • Research in medical education: three decades of progress

• CMAJ, 25 giugno

  • Potential solutions to the problem of conducting systematic reviews of new health technologies

  • Missing the point (estimate)? Confidence intervals for the number needed to treat

  

• BMJ, 22 giugno

  • Evaluating drug treatments for Parkinson's disease: how good are the trials?

• Lancet, 22 giugno

  • Economic implications of non-compliance in health care

  • Drug development for neglected diseases: a deficient market and a public-health policy failure

• JAMA, 19 giugno

  • Estimating Treatment Effects From Observational Data Dissonant and Resonant Notes From the SYMPHONY Trials

• Ann Intern Med, 18 giugno

  • Truth Survival in Clinical Research: An Evidence-Based Requiem?

  • The CONSORT Statement: Explanation and Elaboration

• BMJ, 15 giugno

  • Quality of life measurement: bibliographic study of patient assessed health outcome measures

  • Improving child health: the role of research

  • Randomised trials in surgery: problems and possible solutions

• N Engl J Med, 13 giugno

  • Financial Associations of Authors

• JAMA, 12 giugno

  • Correlation of Quality Measures With Estimates of Treatment Effect in Meta-analyses of Randomized Controlled Trials

• CMAJ, 11 giugno

  • A qualitative study of evidence in primary care: what the practitioners are saying

• Bandolier, giugno 2002

• Arch Intern Med, 10 giugno

  • Adherence to Evidence-Based Therapy: Some Practical Problems

  

• BMJ, 8 giugno

  • Physicians' and patients' choices in evidence based practice

  • Quality improvement report: Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit

  • Clinical endpoints in trials of drugs for cancer: time for a rethink?

• N Engl J Med, 6 giugno

  • When Increased Therapeutic Benefit Comes at Increased Cost

  • Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart Disease

• JAMA, 5 giugno

  • Theme issue: Fourth International Congress on Peer Review in Biomedical Publication

• Ann Intern Med, 4 giugno

  • The Reliability of Medical Record Review for Estimating Adverse Event Rates

  • The Wrong Patient

  • Learning from Our Mistakes: Quality Grand Rounds, a New Case-Based Series on Medical Errors and Patient Safety

• BMJ, 1 giugno

  • Quality improvement report: Safety and efficacy of nurse initiated thrombolysis in patients with acute myocardial infarction

• BMJ, 25 maggio

  • Peer review of statistics in medical research: the other problem

• JAMA, 22/29 maggio

  • Empirical Studies Assessing the Quality of Health Information for Consumers on the World Wide Web. A Systematic Review

  • Health Information on the Internet Quality Issues and International Initiatives

  • The Rational Clinical Examination: Does This Woman Have an Acute Uncomplicated Urinary Tract Infection?

• MJA, 20 maggio

  • Specifying objectives and outcomes for clinical trials

• BMJ, 18 maggio

  • Implications of the EU directive on clinical trials for emergency medicine

• CMAJ, 14 maggio

  • Industry-sponsored pharmaceutical trials and research ethics boards: Are they cloaked in too much secrecy?

  • Complaints and conundrums: an ombudsman–ethicist for CMAJ

  

• Lancet, 11 maggio

  • Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

• Bandolier, maggio 2002

30-aprile - 5 maggio

• BMJ, 4 maggio

  • Why does NICE not recommend laparoscopic herniorraphy?

• N Engl J Med, 2 maggio

  • Participation in Research and Access to Experimental Treatments by HIV-Infected Patients

  • Racial Disparities in Clinical Trials

  • IRB Reform

  • A Central Institutional Review Board for Multi-Institutional Trials

• JAMA, 1 maggio

  • The Rational of Clinical Examination. Does This Patient Have an Acute Thoracic Aortic Dissection?

  • Timing of New Black Box Warnings and Withdrawals for Prescription Medications

  • Safety of Newly Approved Drugs Implications for Prescribing

• CMAJ, 30 aprile

  • Accelerated publication versus usual publication in 2 leading medical journals

  • A medical early warning system

  

• BMJ, 27 aprile

  • Quality improvement report: Clinical screening for developmental dysplasia of the hip in Northern Ireland

  • Health care and the European Union

  • Health policy in the European Union: how it's made and how to influence it

• Lancet, 27 aprile

  • Clinical trials: when to start and when to stop

  • Myocardial infarction: is evidence-based medicine the best?

  

• BMJ, 20 aprile

  • Promoting evidence based practice in maternal care

  • Doctors' knowledge about evidence based medicine terminology

  • Using drugs safely

  • General practitioners' self ratings of skills in evidence based medicine: validation study

  • Factors associated with success in medical school: systematic review of the literature

  • The rise of regulation in the NHS

• Lancet, 20 aprile

  • Causes of prescribing errors in hospital inpatients: a prospective study

• Med J Aust, 15 aprile

  • The Buddha and the search for evidence

  

• Journal Scan, 2-2002

• Bandolier, aprile 2002

• BMJ, 13 aprile

  • Numero tematico: "Too much medicine?"

    • In search of "non-disease"

• Lancet, 13 aprile

  • Quantification of the completeness of follow-up

  • Placebo-controlled trials and the Declaration of Helsinki

• BMJ, 6 aprile

  • Communicating accuracy of tests to general practitioners: a controlled study

  • Explaining risks: turning numerical data into meaningful pictures

  • From guidance to practice: Why NICE is not enough

• Med J Aust, 1 aprile

  • Clinical practice guidelines: time to move the debate from the how to the who

  • Considerations for the safe prescribing and use of COX-2-specific inhibitors

  • The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors

  

• BMJ, 30 marzo

  • Evidence base of clinical diagnosis. 5. Rational, cost effective use of investigations in clinical practice

  • Quality improvement report: Simple intervention to improve detection of child abuse in emergency departments

• Lancet, 30 marzo

  • Evidence-based cellular pathology

• Arch Intern Med, 25 marzo

  • Conflicts of Interest Science, Money, and Health

  

• BMC, Health Service Research

  • Outcomes research in the development and evaluation of practice guidelines

• BMJ, 23 marzo

  • Modern worries, new technology, and medicine

  • Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research

  • Obstacles to answering doctors' questions about patient care with evidence: qualitative study

  • Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign

  • Evidence base of clinical diagnosis. 4. Clinical problem solving and diagnostic decision making: selective review of the cognitive literature

• Ann Intern Med, 19 marzo

  • Deconstructing the Placebo Effect and Finding the Meaning Response

  

• Med J Aust, 18 marzo

  • Hard lessons from a randomised controlled trial

  • Specifying interventions in a clinical trial

• BMJ, 16 marzo

  • Qualitative study of evidence based leaflets in maternity care

  • Use of evidence based leaflets to promote informed choice in maternity care: randomised controlled trial in everyday practice

  • Cost effectiveness of continuing professional development in health care: a critical review of the evidence

  • Evidence base of clinical diagnosis. 3. Designing studies to ensure that estimates of test accuracy are transferable

• Lancet, 16 marzo

  • Epidemiology series. 11. Unequal group sizes in randomised trials: guarding against guessing

• Bandolier, marzo 2002

• JAMA, 13 marzo

  • Improving Quality of Care for Acute Myocardial Infarction The Guidelines Applied in Practice (GAP) Initiative

  • From Clinical Trials to Clinical Practice Bridging the GAP

  

• BMJ, 9 marzo

  • Theme issue: Trusting health information on the net

  • Statistics Notes: Validating scales and indexes

• Lancet, 9 marzo 

  • Epidemiology series 10. Uses and abuses of screening tests

  • Provision of information about drug side-effects to patients

• JAMA, 6 marzo

  • The Rational of Clinical Examination. Is This Patient Clinically Depressed?

• BMC Health Service Research

  • What